The company plans to file next year for an accelerated clearance of its "exon-skipping" treatment, which would compete with one of Sarepta's medicines.

Ongoing cross-checks at the Tevatron experiment reinforce its 2022 measurement of the mass of the W boson, which stands seven ...

Similar to humans going on journeys of self-discovery, quantum computers are also capable of deepening their understanding of ...

As it gears up to submit an approval application next year, Wave Life Sciences has presented fresh phase 2 data showing its ...